Sarepta CEO: ‘We Have, I Believe, a Very Laudable History of Being Extraordinarily Transparent’

Sarepta Therapeutics knew about the death of a patient treated with its experimental gene therapy for a type of limb-girdle muscular dystrophy, but said nothing public for a month. Financial analysts lambasted Sarepta executives for failing to disclose the fatality when the company announced a restructuring that includes stopping work on this limb-girdle program. The…

Read More

FTC to sue PBMs over insulin pricing and rebates

From the FTC’s press release out today: Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’…

Read More

How Kaiser Permanente Consolidated 12 EHRs into 2

Kaiser Permanente consolidated 12 EHR instances across California into two in a matter of hours without disrupting patient care. This project has simplified clinical workflows and improved data consistency, as well as provided a rare example of EHR consolidation executed successfully at scale, said Neil Cowles, the health system’s chief information and technology officer. The…

Read More